Page last updated: 2024-10-15

3-hydroxykynurenine and Psoriasis

3-hydroxykynurenine has been researched along with Psoriasis in 1 studies

3-hydroxykynurenine: RN given refers to cpd without isomeric designation
3-hydroxykynurenine : A hydroxykynurenine that is kynurenine substituted by a hydroxy group at position 3.
hydroxykynurenine : A hydroxy-amino acid that is kynurenine substituted by a single hydroxy group at unspecified position. A "closed" class.

Psoriasis: A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Clement, CC1
D'Alessandro, A1
Thangaswamy, S1
Chalmers, S1
Furtado, R1
Spada, S1
Mondanelli, G1
Ianni, F1
Gehrke, S1
Gargaro, M1
Manni, G1
Cara, LCL1
Runge, P1
Tsai, WL1
Karaman, S1
Arasa, J1
Fernandez-Rodriguez, R1
Beck, A1
Macchiarulo, A1
Gadina, M1
Halin, C1
Fallarino, F1
Skobe, M1
Veldhoen, M1
Moretti, S1
Formenti, S1
Demaria, S1
Soni, RK1
Galarini, R1
Sardella, R1
Lauvau, G1
Putterman, C1
Alitalo, K1
Grohmann, U1
Santambrogio, L1

Other Studies

1 other study available for 3-hydroxykynurenine and Psoriasis

ArticleYear
3-hydroxy-L-kynurenamine is an immunomodulatory biogenic amine.
    Nature communications, 2021, 07-21, Volume: 12, Issue:1

    Topics: Animals; Biogenic Amines; Cell Line, Tumor; Dendritic Cells; Disease Models, Animal; Endothelial Cel

2021